Introduction

  • Fragment-based drug design (FBDD) uses molecular fragments to identify potential drug candidates, formulated as a combinatorial optimization problem. Finding the optimal solution in such a vast search space is challenging, particularly for generating a Pareto front of solutions, which classical samplers struggle to achieve.
  • To address these challenges, we propose a novel method that leverages quantum techniques, offering more efficient navigation of the solution space and a broader set of promising candidates for evaluation.

Method

  • Generate fragment library
  • Translate constraints to QAOA
  • Prepare Ansatz
  • Sample library via QAOA
  • Apply subgraph mining to reduce quantum errors

Conclusions

  • We compared our hybrid QAOA sampler to the classical greedy steepest descent (CGSD) sampler:
    • Figure A: QAOA sampler returns over 5x more samples on average.
    • Figure B: QAOA yields a broader range of pharmacophore scores, including higher scores than CGSD.
    • Figure C: After 10 rounds, QAOA steadily discovers unique optimal molecules, while CGSD struggles to find new ones.
    • This work is a part of a DARPA IMPAQT contract.  More details here.
An image of the sampling solutions count for this work, with Quantum Annealing Optimization Algorithm showing around 350 solutions per sample and Classical Greedy Search at just below 50
An image of the pharmacophore scoring for this work, with Quantum Annealing Optimization Algorithm showing between 0.55 and 0.72 per sample and Classical Greedy Search between 0.6 and 0.67.
An image of the optimal molecule discovery rate for this work, with Quantum Annealing Optimization Algorithm finding many times more than Classical Greedy Search
Published On: November 24th, 2024Categories: News
Share this story, choose your platform!